Morgan Stanley
TIL icon

Morgan Stanley’s Instil Bio TIL Stock Holding History

Morgan Stanley’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.8K Sell
11,934
-7,887
-40% -$63.6K ﹤0.01% 6292
2026
Q1 		$163K Sell
19,821
-69,158
-78% -$561K ﹤0.01% 5955
2025
Q4 		$979K Sell
88,979
-13,959
-14% -$207K ﹤0.01% 5197
2025
Q3 		$1.84M Buy
102,938
+6,630
+7% +$168K ﹤0.01% 4841
2025
Q2 		$2.01M Buy
96,308
+76,957
+398% +$1.61M ﹤0.01% 4699
2025
Q1 		$336K Sell
19,351
-16,690
-46% -$346K ﹤0.01% 5516
2024
Q4 		$688K Buy
36,041
+31,169
+640% +$950K ﹤0.01% 5282
2024
Q3 		$328K Sell
4,872
-185
-4% -$4.36K ﹤0.01% 5575
2024
Q2 		$52K Sell
5,057
-530
-9% -$5.73K ﹤0.01% 6155
2024
Q1 		$60.3K Sell
5,587
-4,527
-45% -$49.6K ﹤0.01% 6145
2023
Q4 		$77.1K Buy
10,114
+8,440
+504% +$61K ﹤0.01% 6245
2023
Q3 		$14.3K Sell
1,674
-2,416
-59% -$24.3K ﹤0.01% 6592
2023
Q2 		$45.1K Sell
4,090
-566
-12% -$6.92K ﹤0.01% 6249
2023
Q1 		$61.5K Buy
4,656
+454
+11% +$6.71K ﹤0.01% 6202
2022
Q4 		$53K Sell
4,202
-7,155
-63% -$354K ﹤0.01% 6268
2022
Q3 		$1.1M Buy
11,357
+4,373
+63% +$500K ﹤0.01% 4829
2022
Q2 		$645K Buy
6,984
+5,401
+341% +$765K ﹤0.01% 5283
2022
Q1 		$340K Sell
1,583
-631
-29% -$147K ﹤0.01% 5611
2021
Q4 		$757K Buy
2,214
+1,848
+505% +$713K ﹤0.01% 5274
2021
Q3 		$131K Sell
366
-2,491
-87% -$930K ﹤0.01% 6217
2021
Q2 		$1.1M Buy
2,857
+2,729
+2,132% +$1.01M ﹤0.01% 5023
2021
Q1 		$64K Buy
+128
New +$65.7K ﹤0.01% 6239

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Morgan Stanley's TIL Position: Q2 2026 in Review

Morgan Stanley reduced its Instil Bio (TIL) stake by 40% in Q2 2026, selling an estimated $63.6K and leaving 11,934 shares worth $91.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6292.

Morgan Stanley first reported a position in TIL in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.01M in Q2 2025. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Morgan Stanley held 11,934 shares of Instil Bio worth $91.8K as of Q2 2026.
  • Morgan Stanley sold 7,887 Instil Bio shares in Q2 2026, an estimated $63.6K.
  • Instil Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6292 holding.
  • Morgan Stanley first reported a position in Instil Bio in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's Instil Bio position peaked at $2.01M in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.